# PCL (Poly-ε-caprolactone) Mesh Pleurodesis

> **NCT03227978** · EARLY_PHASE1 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 10 (estimated)

## Conditions studied

- PCL Pleurodesis

## Interventions

- **COMBINATION_PRODUCT:** PCL mesh pleurodesis

## Key facts

- **NCT ID:** NCT03227978
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2018-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2017-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03227978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03227978, "PCL (Poly-ε-caprolactone) Mesh Pleurodesis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03227978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*